The long half-life of injectable semaglutide means drug levels remain elevated for weeks after your last injection
Panagaki T, Michael M, Hlscher C
NICE recommends that Wegovy treatment should be provided within a specialist weight management service and for a maximum of 2 years
Among 2,570 tirzepatide-treated patients who developed anti-tirzepatide antibodies, 119 experienced injection site reactions
The facial changes caused by use of Ozempic and Wegovy often appear in the form of: A sunken or hollow look in the temples, under-eyes, or mid-face Loose, sagging facial skin due to lost fat in the face More visible indications of facial aging, such as fine lines, wrinkles, and deep creases Those who are losing weight rapidly and/or patients over the age of 40 are most susceptible to developing signs of ozempic face due to the gradual lack of collagen and elastin production over time
As you move to higher doses, your body becomes more accustomed to the medication, which usually lessens the intensity of side effects